CD44 and neoplasm: Our CD44-targetingA6 peptide was conjugated to cholesterol-PEG4 on the surface of LNPsthrough a GGGKKKGK linker, thereby creating a tumor-specific deliverysystem that we refer to as AKPC-LNP.